{"id":2551638,"date":"2023-06-21T21:57:58","date_gmt":"2023-06-22T01:57:58","guid":{"rendered":"https:\/\/platoai.gbaglobal.org\/platowire\/cdc-advisors-approve-limited-use-of-rsv-shots-by-pfizer-and-gsk\/"},"modified":"2023-06-21T21:57:58","modified_gmt":"2023-06-22T01:57:58","slug":"cdc-advisors-approve-limited-use-of-rsv-shots-by-pfizer-and-gsk","status":"publish","type":"platowire","link":"https:\/\/platoai.gbaglobal.org\/platowire\/cdc-advisors-approve-limited-use-of-rsv-shots-by-pfizer-and-gsk\/","title":{"rendered":"CDC Advisors Approve Limited Use of RSV Shots by Pfizer and GSK"},"content":{"rendered":"

\"\"<\/p>\n

The Centers for Disease Control and Prevention (CDC) recently approved the limited use of respiratory syncytial virus (RSV) shots by Pfizer and GlaxoSmithKline (GSK). This decision comes after the CDC’s Advisory Committee on Immunization Practices (ACIP) reviewed data on the safety and efficacy of the vaccines.<\/p>\n

RSV is a common respiratory virus that can cause serious illness in infants, young children, and older adults. It is the leading cause of hospitalization for infants in the United States. There is currently no specific treatment for RSV, so prevention is key.<\/p>\n

The RSV shots developed by Pfizer and GSK are designed to prevent severe RSV disease in infants and young children. The vaccines are given as a series of injections during the first year of life. The ACIP recommended that the vaccines be given to certain high-risk infants, including those born prematurely and those with certain medical conditions.<\/p>\n

The decision to approve the limited use of RSV shots by Pfizer and GSK is a significant step forward in the fight against RSV. However, it is important to note that the vaccines are not yet widely available. Pfizer and GSK are still working to ramp up production and distribution of the vaccines.<\/p>\n

In the meantime, there are other steps that parents and caregivers can take to help prevent RSV. These include washing hands frequently, avoiding close contact with sick people, and keeping infants away from large crowds during RSV season (which typically runs from November to April).<\/p>\n

It is also important for parents and caregivers to be aware of the signs and symptoms of RSV. These can include coughing, wheezing, fever, and difficulty breathing. If an infant or young child shows any of these symptoms, they should be taken to a healthcare provider right away.<\/p>\n

In conclusion, the approval of limited use of RSV shots by Pfizer and GSK is a positive development in the fight against this common respiratory virus. However, it is important to remember that the vaccines are not yet widely available and that prevention measures such as hand washing and avoiding close contact with sick people are still crucial. Parents and caregivers should also be aware of the signs and symptoms of RSV and seek medical attention if necessary.<\/p>\n